Top Markets
Coin of the day
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Kedudukan dalam Saham #13829
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Harga Saham
$4.36
Modal Pasaran
$457.32M
Perubahan (1 hari)
0.69%
Perubahan (1 tahun)
289.29%
Negara
US
Perdagangan Relmada Therapeutics, Inc. (RLMD)

Kategori

Sejarah pecahan saham untuk Relmada Therapeutics, Inc. (RLMD)
Saham Relmada Therapeutics, Inc. (simbol: RLMD) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 31, 2026.
Satu saham RLMD yang dibeli sebelum Aug 31, 2026 kini bersamaan dengan 0 saham RLMD.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH